Glucocorticoid effects on the skeletal muscle differentiation program: Analysis of clonal proliferation, morphological differentiation and the expression of muscle-specific and regulatory genes

Endocrine Research

Volumn 23, Issue 1-2, 1997, Pages 37-57

  Montano, Monica M ^a,b   Lim, Robert W ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; GROWTH RATE; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 0031006704     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1080/07435809709031841     Document Type: Article

References (32)

1. Grob D, Arsura EL, Brunner NG, et al. 1987 The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci 505: 472-499.
2. Braun S, Tranchant C, Vilquin J-T, et al. 1989 Stimulating effects of prednisolone on acetylcholine receptor expression and myogenesis in primary culture of newborn rat muscle cells. J Neurol Sci 92: 119-131.
3. Whitson PA, Stuart CA, Huls MH, et al. 1989 Dexamethasone effects on creatine kinase activity and insulin-like growth factor receptors in cultured muscle cells. J Cell Physiol 140: 8-17.
4. Kaplan I, Blakely BT, Pavlath GK, et al. 1990 Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis. Proc Natl Acad Sci USA 87: 8100-8104.
5. Sklar RM, Brown RH, Jr. 1991 Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro. J Neurol Sci 101: 73-81.
6. Sklar RM, Hudson A, Brown RH, Jr. 1991 Glucocorticoids increase myoblast proliferation rates by inhibiting death of cycling cells. In Vitro Cell Dev Biol 27A: 433-434.
7. Max JR, Thomas JW, Banner C, et al. 1987 Glucocorticoid receptor-mediated induction of glutamine synthase in skeletal muscle cells in vitro. Endocrinology 120: 1179-1183.
8. Konagaya M, Bernard PA, Max SR. 1986 Blockdade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology 119: 375-380.
9. Florini JR, Ewton DZ, Magri KA. 1991 Hormones, growth factors, and myogenic differentiation. Annu Rev Physiol 53: 201-216.
10. Harpold MM, Evans RM, Salditt-Georgieff M, et al. 1979 Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell 17: 1025-1035.
11. Lim RW, Yang W-L, Yu H. 1995 Signal transduction pathway-specific desensitization of orphan nuclear receptor TIS1 expression. Biochem J 308: 785-789.
12. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
13. Lim RW, Varnum BC, Herschman HR. 1987 Cloning of tetradecanoyl phorbol ester-induced 'primary response' sequences and their expression in density-arrested Swiss 3T3 cells and a TPA non-proliferative variant. Oncogene 1: 263-270.
14. Herbomel P, Bourachot B, Yaniv M. 1984 Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39: 653-662.
15. Gorman CM, Moffat LF, Richard BH. 1982 Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044-1051.
16. Davis RL, Weintraub H, Lassar AB. 1987 Expression of a single transfected cDNA converts fibroblast to myoblast. Cell 51: 987-1000.
17. Wright WE, Sassoon DA, Lin VK. 1993 Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD1. Cell 56: 607-617.
18. Lassar AB, Thayer MJ, Overell RW, et al. 1989 Transformation by activated ras or fos prevents myogenesis by inhibiting expression of myoD1. Cell 58: 659-667.
19. Tapscott SJ, Davis RL, Thayer MJ, et al. 1988 MyoD1: A nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242: 405-411.
20. Olson EN, Brennan TJ, Chakraborty T, et al. 1991 Molecular mechanisms of cellular growth symposium. Molecular control of myogenesis: Antagonism between growth and differentiation. Mol Cell Biochem 104: 7-13.
21. Evans RM. 1989 Molecular characterization of the glucocorticoid receptor. Rec Prog in Hormone Res 45: 1-27.
22. Burnstein KL, Cidlowski JA. 1989 Regulation of gene expression by glucocorticoids. Ann Rev Physiol 51: 683-699.
23. Munck A, Mendel DB, Smith LI, et al. 1990 Glucocorticoid receptors and action. Am Rev Respir Dis 141: S2-S10.
24. Florini JR, Magri KA, Ewton DZ, et al. 1991 "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266: 15917-15923.
25. Quinn LS, Steinmetz B, Maas A, et al. 1994 Type-1 insulin growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation. J Cell Physiol 159: 387-398.
26. Quinn LS, Roh JS. 1993 Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation. Exp Cell Res 208: 504-508.
27. Quinn LS, Ehsan M, Steinmetz B, et al. 1993 Ligand-dependent inhibition of myoblast differentiation by overexpression of the type-1 insulin-like growth factor receptor. J Cell Physiol 156: 453-461.
28. Bengal E, Ransone L, Scharfmann R, et al. 1992 Functional antagonism between c-jun and myoD proteins: A direct physical association. Cell 68: 507-519.
29. Pedraza-Alva G, Zingg JM, Jost JP. 1994 AP-1 binds to a putative cAMP response element of the MyoD1 promoter and negatively modulates MyoD1 expression in dividing myoblasts. J Biol Chem 269: 6975-6985.
30. Benezra R, Davis RL, Lockshon D, et al. 1990 The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49-59.
31. Yang-Yen HF, Chambard JC, Sun YL, et al. 1990 Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215.
32. Jonat C, Rahmsdorf HJ, Park KK, et al. 1990 Antitumor promotion and antiinflammation: down-modulation of ap-1 (fos/jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.